AU3487799A - Improved live attenuated viruses for use as vectors or vaccines - Google Patents

Improved live attenuated viruses for use as vectors or vaccines

Info

Publication number
AU3487799A
AU3487799A AU34877/99A AU3487799A AU3487799A AU 3487799 A AU3487799 A AU 3487799A AU 34877/99 A AU34877/99 A AU 34877/99A AU 3487799 A AU3487799 A AU 3487799A AU 3487799 A AU3487799 A AU 3487799A
Authority
AU
Australia
Prior art keywords
vaccines
vectors
live attenuated
attenuated viruses
improved live
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34877/99A
Inventor
Nora M. Chapman
Steven M. Tracy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of AU3487799A publication Critical patent/AU3487799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32341—Use of virus, viral particle or viral elements as a vector
    • C12N2770/32343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32361—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU34877/99A 1998-04-09 1999-04-09 Improved live attenuated viruses for use as vectors or vaccines Abandoned AU3487799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8113898P 1998-04-09 1998-04-09
US60081138 1998-04-09
PCT/US1999/007854 WO1999053034A1 (en) 1998-04-09 1999-04-09 Improved live attenuated viruses for use as vectors or vaccines

Publications (1)

Publication Number Publication Date
AU3487799A true AU3487799A (en) 1999-11-01

Family

ID=22162325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34877/99A Abandoned AU3487799A (en) 1998-04-09 1999-04-09 Improved live attenuated viruses for use as vectors or vaccines

Country Status (2)

Country Link
AU (1) AU3487799A (en)
WO (1) WO1999053034A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1354064A2 (en) 2000-12-01 2003-10-22 Visigen Biotechnologies, Inc. Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity
US6724923B2 (en) 2001-04-13 2004-04-20 Ge Medical Systems Global Technology Co., Llc Automatic coil selection of multi-receiver MR data using fast prescan data analysis
WO2010111686A2 (en) 2009-03-27 2010-09-30 Life Technologies Corp Labeled enzyme compositions, methods & systems
US11826418B1 (en) 2023-01-06 2023-11-28 King Faisal University Virus-like particle (VLP)-based vaccine against CVB4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine

Also Published As

Publication number Publication date
WO1999053034A1 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
HUP0103908A3 (en) Novel infulenza virus vaccine composition
ZA200004956B (en) Vaccine composition.
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
IL137998A0 (en) Combined vaccine compositions
AU4071595A (en) Live recombinant avian vaccine using an avian herpesvirus as vector
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU7620300A (en) Hooded garment with storable mask or goggles
HUP9903713A3 (en) Stabilisers for live vaccines
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
AU2002229390A1 (en) Attenuated live vaccine
AU7105598A (en) Attenuated, invasive vaccines against fish pathogens
AU1508699A (en) Live attenuated influenza vaccine
IL145447A0 (en) Composition for the preservation of infectious recombinant adenoviruses
AU2462899A (en) Live vaccine against brucellosis
GB9822714D0 (en) Vaccines
AU3058897A (en) Attenuated canine parvovirus vaccine
IL139467A0 (en) Vaccine
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
AU1386100A (en) Stable, attenuated rabies virus mutants and live vaccines thereof
AU2001280674A1 (en) Mini-adenoviral vector system for vaccination
GB9809666D0 (en) Modified viruses
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
AU2144499A (en) Live attenuated salmonella vaccine
GB9817082D0 (en) Attenuated poliovirus vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase